Listen to Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.
In this episode, Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest immuno-oncology developments in the treatment of urothelial cancer.
Presenters:
Alain Ravaud, MD, PhD
Professor of Medical Oncology
Head of Department of Medical Oncology
Bordeaux University Hospital
Bordeaux, France
Marine Gross-Goupil, MD, PhD
Medical Oncologist
Saint-André Hospital
Bordeaux University Hospital
Bordeaux, France
Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.
Link to full program:
https://bit.ly/3kJC5SL